A new study by researchers at the Case Western Reserve University School of Medicine finds those who received the Moderna COVID-19 mRNA vaccine are less likely to experience "breakthrough" COVID-19 cases, compared to recipients ...
Jan 20, 2022
0
154
Pfizer expects a COVID-19 vaccine targeting the Omicron variant to be ready in March, the company's head said Monday.
Jan 10, 2022
0
0
U.S. regulators on Friday shortened the time that people who received Moderna's COVID-19 vaccine have to wait for a booster—to five months rather than six.
Jan 7, 2022
0
23
An influential government advisory panel is considering COVID-19 boosters for younger teens, as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike.
Jan 5, 2022
0
0
(HealthDay)—Patient-reported data indicate certain factors, such as vaccine brand (mRNA-1273) and younger age, are associated with an increased risk for adverse effects following COVID-19 vaccination, but serious adverse ...
Jan 5, 2022
0
10
The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.
Jan 3, 2022
0
22
The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
Dec 24, 2021
0
248
The World Health Organization on Tuesday authorised its 10th COVID-19 vaccine—Nuvaxovid from US firm Novavax.
Dec 21, 2021
0
7
Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.
Dec 17, 2021
0
11
The EU's drug regulator on Thursday allowed member states to use Pfizer's new COVID pill ahead of its formal approval, as an emergency measure to curb an Omicron-fuelled wave.
Dec 16, 2021
0
7
